CRP and COVID-19: Other outcome measures were the increase in C-reactive protein (CRP) levels [32], ARDS development [42], COVID-19 severity [45], length of stay (LOS) of SARS-CoV-2-infected patients [38] and a composite outcome including ICU referral and ICU LOS, need for endotracheal intubation, and mortality [35].